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Background: Congenital esophageal stenosis (CES) is a rare condition frequently associated with esophageal atresia
(EA). There are limited data from small series about the presentation, treatment, and outcomes of CES.
Methods: Medical records of all patients with CES included in the French Network on Esophageal Malformations
and Congenital Diseases were reviewed retrospectively with regard to diagnosis, treatment, and outcome.
Results: Over 18 years, 61 patients (30 boys) had CES, and 29 (47%) of these patients also had EA. The mean age at
diagnosis was 24 months (1 day to 14 years) and was younger in patients with CES and EA than in those with
isolated CES (7 vs. 126 months, p < 0.05). Twenty-one of the 61 patients with CES had no clinical symptoms: in three
patients, the findings were incidental, and in 18 of the 29 patients with associated EA, CES was diagnosed at the
time of surgical repair of EA or during a postoperative systematic esophageal barium study. In the 40 other patients,
at diagnosis, 50% presented with dysphasia, 40% with vomiting, 50% with food impaction, and 42% with respiratory
symptoms. Diagnosis of CES was confirmed by esophageal barium study (56/61) and/or esophageal endoscopy
(50/61). Sixteen patients had tracheobronchial remnants (TBR), 40 had fibromuscular stenosis (FMS), and five had
membrane stenosis (MS). Thirty-four patients (56%) were treated by dilation only (13/34 remained asymptomatic at
follow-up); 15 patients were treated by dilation but required later surgery because of failure (4/15 remained
asymptomatic at follow-up); and nine patients had a primary surgical intervention (4/9 were asymptomatic at
follow-up). Dilation was complicated by esophageal perforation in two patients (3.4%). At follow-up, dysphagia
remained in 36% (21/58) of patients, but the incidence did not differ between the EA and the isolated CS groups
(10/29 vs. 7/32, p = 0.27).
Conclusions: CS diagnosis can be delayed when associated with EA. Dilation may be effective for treating patients
with FMS and MS, but surgical repair is often required for those with TBR. Our results show clearly that, regardless of
the therapeutic option, dysphagia occurs frequently, and patients with CES should be followed over the long term.
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Figure 1 CES in the lower esophagus in a child with EA.
Esophageal barium study.
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Congenital esophageal stenosis (CES) is a very rare clinical
condition found in 1 per 25,000 to 50,000 live births, al-
though the true incidence remains unknown. CES is char-
acterized by an intrinsic circumferential narrowing of the
esophageal lumen that it is present at birth, although not
necessarily symptomatic in the neonatal period [1]. Its
etiology remains unknown, but an embryologic origin has
been suggested. There are three histological types of CES:
ectopic tracheobronchial remnants in the esophageal wall
(TBR), segmental fibromuscular hypertrophy of the muscle
and submucosal layers (FMS), and a membranous dia-
phragm or stenosis (MS) [2]. CES is frequently associated
with esophageal atresia (EA) [3,4]. The definitive preopera-
tive diagnosis is often difficult, and there are few data about
treatment and outcomes from small series. The aim of this
study was to assess the circumstances of diagnosis, manage-
ment, and outcomes of CES in a large multicenter cohort.
Methods
All 38 participating centers of the French Network on
Esophageal Malformations and Congenital Disease were
asked to search in their databases for patients treated for
CES in their institution during the past 18 years. Sixty-one
patients with CES were identified. The data were obtained
retrospectively from the patients’ clinical, radiological,
endoscopic, and operative records. We analyzed clinical
characteristics including sex, age at diagnosis, clinical
symptoms at presentation, and associated malformations.
Ladd’s classification of EA was used when appropriate. The
management and outcomes of CES were also reviewed.
We collected histological information when available.
Statistical analysis
The data were compared between the patients with iso-
lated CES and those with CES associated with EA using
the χ2 test or Wilcoxon test. A p value < 0.05 was con-
sidered significant.
Results
Sixty-one patients were diagnosed with CES during the
study period. The female-to-male ratio was 1 (30 boys,
31 girls). At the time of diagnosis, the patients’ ages
ranged from 1 day to 14 years (mean age at diagnosis:
2 years); seven (11%) with CES were diagnosed after the
age of 5 years. In 29/61 patients (48%), CES was associ-
ated with type III EA (EA associated with a distal
tracheoesophageal fistula).
Clinical symptoms at presentation
Patients with CES associated with EA were younger at
the time of diagnosis than were patients with isolated
CES (7 vs 126 months, p < 0.05). Twenty-one patients
with CES (34%) did not present with any symptom at thetime of diagnosis: 18 (of 29 with associated EA) were diag-
nosed at the time of surgical repair of EA or postoperatively
at the time of control esophageal opacification, and in three
patients the findings were incidental. For one of the pa-
tients whose finding was incidental, CES was diagnosed at
birth in the maternity ward when a nasogastric tube was
passed for desobstruction; for the other two patients with
associated EA whose findings were incidental, CES was
diagnosed endoscopically during follow-up of EA.
Forty of the 61 children with CES (66%) presented
with symptoms at a mean age of 39 months (range 1 to
166 months). Dysphagia (50%), food impaction (50%),
and repeated vomiting (40%) were the most frequent
symptoms. For six patients, CES was revealed during
examination of an esophageal retained foreign body. In
addition to gastrointestinal symptoms, respiratory signs
(respiratory failure, dyspnea) were observed in 27% of
patients. At diagnosis, 35% of the patients were classi-
fied as malnourished (Z-score weight for height < −2
SD). Repeated vomiting, food impaction, and impaired
growth were more frequently observed as revealing
symptoms in the group with isolated CES than in pa-
tients with CES associated with EA (all p < 0.05).
Diagnosis of CES
An esophageal barium study identified esophageal stenosis
in 56/61 patients (91%), (Figure 1). Endoscopy performed
in 50/61 patients (82%) confirmed the diagnosis in all pa-
tients with stenosis associated with normal aspects of the
mucosa (Figure 2). Endoscopic ultrasonography was per-
formed in only one patient. The stenosis was located at the
level of the gastroesophageal junction in three patients, 1
Figure 2 Endoscopic aspect of a CES.
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in the median part of the esophagus in 12, and in the upper
part of the esophagus in six patients (Table 1). Computed
tomography scanning was performed in eight patients and
confirmed all CES diagnoses but did not show any signs of
TBR in the esophageal wall.
Pathology examination of the stenosis was available in
18 patients at the time of operation. TBR comprising
either mature or immature cartilage was found in 12 pa-
tients. Fibromuscular thickening and circumferential
proliferation of the smooth muscle fibers were found in
the other six patients. In absence of histological con-
firmation of TBR stenosis and in absence of endoscopic
aspect of membrane stenosis (MS), diagnostic of FMS
was usually retained, probably leading to an overesti-
mation of the number of FMS.
Using endoscopic and histological data when available,
the type of stenosis was classified as TBR (n = 16), FMS
(n = 40), or MS (n = 5). No patient presented with multi-
ples stenoses. MS was not found in any patient with EA.
Treatment and outcomes
Esophageal dilation was the first-line treatment of 49/58
patients (84%), (Figure 3). Data concerning treatment
were missing for three patients lost to follow-up afterTable 1 Location of CES
Upper esophagus
Isolated CES (n = 32) 6 (19%)
CES associated with EA (n = 29) 0 (%)
All patients (n = 61) 6 (10%)the initial diagnosis. Savary bougienage (39 sessions) and/
or balloon dilation (103 sessions) were performed under
general anesthesia. Since no technique have been shown
to be superior to the other, the choice of dilation tech-
nique (bouginage or hydrostatic dilation) depended on
personal experience or preference. The median number of
dilations per patient was 2.5 (range: 1 to 11). Sixteen pa-
tients had Savary bouginage dilation (3 to 5 dilations per
patients), 35 were treated with balloon dilation (2 to 11 di-
lations per patients). Two patients had successively Savary
and balloons dilation. Esophageal perforation occurred in
two patients (3.4%). One perforation occurred after Savary
dilation, the other after balloon dilation. The first patient
who presented perforation after Savary dilation was not
operated first. Conservative treatment (IV antibiotic and
parenteral nutrition) was effective but this patient needs fi-
nally a surgical resection. The other patient who presented
esophageal perforation after balloon dilatation (8 sessions)
had surgical resection and coloplasty.
Thirteen of the 49 patients (27%) became free from
symptoms after endoscopic dilation, whereas 36/49 (73%)
had persistent symptoms (moderate to severe dysphagia);
15 (30%) required additional surgical treatment (Figure 2).
Nine patients (16%) received first-line surgical treat-
ment; four became free from symptoms, but the other five
had persistent dysphagia at the follow-up 1 to 18 years
later. Fifteen patients were operated because of persistent
symptoms after dilatation. Four patients were symptom
free, while 11 of them had persistent symptoms after sur-
gery. In total, 24 patients underwent surgical treatment
(Figure 3). Surgical treatment comprised resection of the
stenotic segment and end-to-end esophageal anastomosis.
Five out of 9 who underwent first line surgery and 11/15
operated because of endoscopic dilation failure remained
symptomatic after surgery. At total 16/24 (66%) of surgical
patients remained symptomatic after surgery. In those
children presenting persistent dysphagia we cannot defini-
tively separate persistent esophageal stricture from esopha-
geal dysmotility.
At follow-up (median: 33 months; range: 1 months to
20 years), dysphagia persisted in 64% (37/58) of patients
regardless of the treatment. The incidence did not differ
between the group with CES and EA and the isolated
CES group (10/29 vs 7/32; p = 0.27) (Table 1). All 15 pa-
tients with TBR for whom follow-up was available
underwent operative repair; 10 were treated by esopha-
geal dilatation before surgery.Middle esophagus Lower esophagus Cardia
6 (19%) 18 (56%) 2 (6%)
6 22 1
12 (20%) 40 (65%) 3 (5%)
Endoscopic dilation
n=49






















Figure 3 Treatment and outcomes.
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To our knowledge, our study is the largest reported and
thus provides, for the first time, a description of the cir-
cumstances of diagnosis and the outcomes of this very
rare malformation. Multiple CES lesions, the rarest form
of this anomaly, were not observed in our series, and
only a few cases have been reported [5,6]. CES without
associated EA is diagnosed rarely in the neonatal period
because symptoms usually start after the introduction of
solid foods, and diagnosis can be delayed into the second
decade of life, as found in our series. The classical re-
vealing circumstance is food impaction, but other signs
may precede this, such as failure to thrive, aspiration
pneumonia, and dysphagia, as we observed in our series.
Of interest, we found that the diagnosis of isolated CES
can be made during the initial examination in the mater-
nity ward when a gastric tube test is used to rule out
EA, as we observed in one patient.
CES associated with EA is diagnosed in only 62% (18/29)
of patients at the time of the initial esophageal surgical
repair, meaning that even in patients with symptoms of EA,
the diagnosis of CES can be delayed. In addition to the nu-
merous causes of feeding problems in EA (e.g., motility
disorders, esophagitis, and anastomotic stenosis), CES
should be considered when symptoms of dysphagia and
food impaction persist in children after EA repair. A post-
operative esophageal barium study is helpful for revealing
this lesion [7].
Conservative treatment (dilation with a Savary bougie
or balloon) is used as the first-line treatment in most
cases (49/58), but only 27% (13/49) of our patients be-
came asymptomatic after endoscopic dilation. Persistentdysphagia may indicate failure of dilation, but it can also
be related to esophageal dysmotility observed in patients
with CES associated EA or with isolated CES [8].
Despite the lack of large published series, some authors
have suggested that the therapeutic approach for CES
should depend on the etiology and that dilation is ineffect-
ive in patients with TBR, and that therefore these patients
should undergo operative repair [6]. In our series, all pa-
tients with TBR had first- or second-line surgical treat-
ment that confirmed the presence of the TBR form of
CES, which is resistant to dilation. Of interest, all perfora-
tions occurred in children with TBR, reinforcing the need
for first-line surgery in patients with this form of CES.
However, because we did not have a histological analysis
of the lesions for the patients who responded to dilation,
we cannot formally exclude the possibility that TBR can
respond to esophageal dilation. Computed tomography
scanning (CTS) was indeed performed in eight patients
and confirmed all CES diagnoses but did not show any
signs of tracheobronchial remnants in the esophageal wall,
and so did not allow to diagnose TBR-CES. CTS is not a
good method to differentiate TBR-CES and fibromuscular
stenosis (FMS) CES. Miniprobe endoscopic esophageal
ultrasound is a promising method to discriminate FMS
from TBR [9], but this method was not used in this series.
The definitive preoperative diagnosis of CES is often diffi-
cult to make. The definition and classification of CES pro-
posed by Nihoul-Fékété was used in our study. This
classification delineates 3 forms of CES: tracheobronchial
remnants, fibromusclar stenosis and membranous dia-
phragm in the wall of the esophagus. In absence of histo-
logical confirmation of TBR stenosis and in absence of
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of FMS was retained, probably leading to an overesti-
mation of the number of FMS. We cannot exclude TBR in
the group of patients in which the dilations were effective.
Since there is at present time no consensus on treatment
of CS, the type of initial treatment (surgical or endoscopic)
varied according to the teams, and also depended if the
patient was in a surgical or a gastroenterological unit.
In patients with FMS or suspected FMS, balloon dilation
or bougienage may be the treatment of choice because
dilation was effective in 38% of our patients without the
need for second-line surgery and without causing any
complications. Some authors have reported the addition
of endoscopic incision or partial resection of the dia-
phragm to esophageal dilatation [10,11], but we found
these to be of no use in our study.
Finally, an important finding of our study is that surgery
should not been considered a definite curative option
because 66% (16/24) of our patients remained symptom-
atic after surgery (Figure 3). Our results show clearly that,
regardless of the therapeutic option, dysphagia often
remains and suggest that patients with CES should be
followed over the long term.
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